.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,717,889

« Back to Dashboard

Claims for Patent: 7,717,889

Title:Disinfectant delivery system and method of providing alcohol free disinfection
Abstract: A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body. When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure.
Inventor(s): Keaty, Jr.; Thomas (Crystal Lake, IL), Skiba; Barbara T. (Chicago, IL), Hanifi; Paul H. (Barrington Hills, IL)
Assignee: Sage Products, Inc. (Cary, IL)
Application Number:11/426,611
Patent Claims: 1. A method of infection reduction by preparation of a patient before an invasive procedure, comprising: a. providing a blended cloth comprising a fibrous mat impregnated with a disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and b. using the impregnated cloth to disinfect at least a portion of the patient up to several days prior to the invasive procedure proximate the location of the invasive procedure, and c. releasing all of the CHG from the fibrous mat during step b.

2. The method according to claim 1, in which method step "a" comprises providing a blended cloth comprising first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of said second fibers, said blended cloth having an absorbency by weight greater than the weight of said blended cloth.

3. The method according to claim 1, in which step "a" comprises providing a plurality of said blended cloths in a package, and step "b" comprises using each cloth to disinfect a discrete portion of the patient.

4. The method according to claim 1 including the further step of using the disinfecting solution a further time immediately prior to the invasive procedure.

5. The method according to claim 1 in which said fibrous mat consists of polyester fibers.

6. A method of infection reduction by preparation of a patient before an invasive procedure, comprising: a. providing a blended cloth comprising a fibrous mat composed of polyester fibers impregnated with a disinfecting solution having chlorhexidine gluconate (CHG) as an active ingredient and having no alcohol, and b. using the impregnated cloth to disinfect at least a portion of the patient at least one day prior to, and up to several days prior to, the invasive procedure proximate the location of the invasive procedure.

7. The method according to claim 6, in which method step "a" comprises providing a blended cloth comprising first fibers and second fibers, with the quantity by weight of said first fibers generally being greater than the quantity by weight of said second fibers, said blended cloth having an absorbency by weight greater than the weight of said blended cloth.

8. The method according to claim 6, in which step "a" comprises providing a plurality of said blended cloths in a package, and step "b" comprises using each cloth to disinfect a discrete portion of the patient.

9. The method according to claim 6, in which step "b" includes releasing substantially of the CHG from the fibrous mat.

10. The method according to claim 6 including the further step of using the disinfecting solution a further time immediately prior to the invasive procedure.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc